Literature DB >> 10700917

Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.

M K Beuria1, K K Mohanty, K Katoch, U Sengupta.   

Abstract

IgG subclasses against lipoarabinomannan of mycobacteria were analyzed in the sera of leprosy patients. Patients with active leprosy [tuberculoid and lepromatous, patients undergoing erythema nodosum leprosum (ENL) and reversal reactions] and inactive cases (tuberculoid and lepromatous who were cured after chemotherapy) were included in this study. Active lepromatous patients had higher levels of IgG subclasses, except IgG4, compared to active tuberculoid patients. Some of the inactive cases (lepromatous patients cured after chemotherapy) were positive for the IgG1, IgG2 and IgG3 subclasses. However, their levels are lower than active lepromatous cases. On the other hand, no difference in the subclass levels between the active and inactive tuberculoid groups could be observed. While a significant fall in the level of IgG3 in ENL was observed as compared to lepromatous leprosy without ENL, higher levels of IgG1 and IgG2 were found in patients with reversal reactions compared to their active counterparts without reactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10700917

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  2 in total

1.  Analysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India.

Authors:  Rupendra Jadhav; Lavanya Suneetha; Ravindra Kamble; Vidyagouri Shinde; Karuna Devi; Meher Vani Chaduvula; Renuka Raju; Sujai Suneetha; Peter G Nicholls; Wim H van Brakel; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08

Review 2.  A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.

Authors:  Anastasia Polycarpou; Stephen L Walker; Diana N J Lockwood
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.